Sensory Modulation Disorder and its Neural Circuitry in Adults with ADHD: A Pilot Study.


Journal

Brain imaging and behavior
ISSN: 1931-7565
Titre abrégé: Brain Imaging Behav
Pays: United States
ID NLM: 101300405

Informations de publication

Date de publication:
Apr 2021
Historique:
pubmed: 10 8 2020
medline: 28 4 2021
entrez: 10 8 2020
Statut: ppublish

Résumé

Compared to healthy controls (HCs), individuals with attention-deficit/hyperactivity disorder (ADHD) exhibit more symptoms of sensory processing disorder (SPD), which is associated with difficulties in educational and social activities. Most studies examining comorbid SPD-ADHD have been conducted with children and have not explored relations to brain volumes. In this pilot study, we assessed a subtype of SPD, sensory modulation disorder (SMD), and its relation to select brain volumes in adults with ADHD. We administered part of the Sensory Processing 3-Dimensions Scale (SP3D) to assess subtypes of SMD and collected structural imaging scans from 25 adults with ADHD and 29 healthy controls (HCs). Relative to HCs, subjects with ADHD scored higher on sensory craving (SC) and sensory under-responsivity (SUR) subscales. Although sensory over-responsivity (SOR) was marginally higher, this was no longer true when accounting for co-occurring anxiety. In individuals with ADHD, both SC and SUR were positively associated with amygdalar volume, SUR was also positively associated with striatal volume, whereas SOR was negatively associated with posterior ventral diencephalon volume. These preliminary findings suggest that SC and SUR may be characteristic of ADHD while SOR may be driven by co-occurring anxiety. Because different modalities were associated with different brain volumes, our findings also suggest that the modalities may involve unique neural circuits, but with a partial overlap between SC and SUR. These pilot data provide support for conducting studies examining SMD in larger samples of adults with ADHD to determine reproducibility, applicability and implications of these findings.

Identifiants

pubmed: 32770315
doi: 10.1007/s11682-020-00302-w
pii: 10.1007/s11682-020-00302-w
pmc: PMC10655817
mid: NIHMS1618779
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

930-940

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB015896
Pays : United States
Organisme : NCRR NIH HHS
ID : P41 RR014075
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD067744
Pays : United States
Organisme : NIH HHS
ID : R01 HD067744-01A1
Pays : United States

Références

J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Res Dev Disabil. 2009 Nov-Dec;30(6):1468-80
pubmed: 19665348
Phys Occup Ther Pediatr. 2019;39(1):94-106
pubmed: 29465281
J Atten Disord. 2016 Dec;20(12):1066-1075
pubmed: 24464326
Br J Psychiatry. 2009 Mar;194(3):204-11
pubmed: 19252145
Eur Arch Psychiatry Clin Neurosci. 2007 Oct;257(7):371-7
pubmed: 17902010
Am J Occup Ther. 2014 Sep-Oct;68(5):522-30
pubmed: 25184464
Res Dev Disabil. 2011 May-Jun;32(3):1154-62
pubmed: 21324640
J Neural Transm (Vienna). 2008;115(2):211-20
pubmed: 17994185
Neuroimage Clin. 2015 May 21;8:422-8
pubmed: 26106567
Am J Occup Ther. 2016 Mar-Apr;70(2):7002250010p1-9
pubmed: 26943106
Am J Occup Ther. 2008 Jul-Aug;62(4):393-406
pubmed: 18712002
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Autism Dev Disord. 2009 Feb;39(2):197-209
pubmed: 18642069
Res Dev Disabil. 2012 May-Jun;33(3):804-18
pubmed: 22236629
J Comp Neurol. 1991 Nov 8;313(2):295-325
pubmed: 1765584
J Cogn Neurosci. 2009 Jan;21(1):83-92
pubmed: 18476760
Psychiatry Res. 2013 Jan 30;205(1-2):117-26
pubmed: 23017654
Phys Occup Ther Pediatr. 2015 Feb;35(1):1-12
pubmed: 24712841
Psychol Assess. 2004 Sep;16(3):330-4
pubmed: 15456389
Eur Psychiatry. 2017 Jun;43:51-57
pubmed: 28371743
Front Integr Neurosci. 2010 Mar 29;4:8
pubmed: 20556242
Mol Autism. 2019 Feb 4;10:4
pubmed: 30740199
Am J Occup Ther. 2007 Mar-Apr;61(2):135-40
pubmed: 17436834
Biol Psychiatry. 2011 May 1;69(9):857-66
pubmed: 21183160
Cell Mol Neurobiol. 2003 Oct;23(4-5):727-38
pubmed: 14514027
Biol Psychiatry. 2005 Jun 1;57(11):1215-20
pubmed: 15949990
Dev Med Child Neurol. 1997 Jul;39(7):464-8
pubmed: 9285437
Am J Occup Ther. 2004 May-Jun;58(3):294-302
pubmed: 15202627
J Atten Disord. 2015 May;19(5):368-79
pubmed: 24378286
Neuroimage. 1999 Jan;9(1):18-45
pubmed: 9918726
Biol Psychiatry. 2005 Jun 1;57(11):1263-72
pubmed: 15949998
Dev Med Child Neurol. 2001 Jun;43(6):399-406
pubmed: 11409829
Cogn Neurosci. 2016 Jan-Oct;7(1-4):138-59
pubmed: 26274315
Cerebellum. 2011 Dec;10(4):770-92
pubmed: 21630084
J Autism Dev Disord. 2008 Mar;38(3):516-29
pubmed: 17917804
J Atten Disord. 2010 Mar;13(5):468-78
pubmed: 19372496
Psychol Bull. 1987 Mar;101(2):213-32
pubmed: 3562706
Front Hum Neurosci. 2013 Dec 16;7:862
pubmed: 24379772
J Atten Disord. 2017 Aug;21(10):835-845
pubmed: 25091585
Autism. 2009 May;13(3):215-28
pubmed: 19369385
Neuroimage Clin. 2013 Jun 23;2:844-53
pubmed: 24179836
J Autism Dev Disord. 2010 Dec;40(12):1495-504
pubmed: 20383658
Dev Med Child Neurol. 1999 Sep;41(9):608-15
pubmed: 10503919
J Autism Dev Disord. 2018 Dec;48(12):4231-4249
pubmed: 30019274
Child Dev. 2008 Jan-Feb;79(1):100-13
pubmed: 18269511
Trends Cogn Sci. 2009 Oct;13(10):447-54
pubmed: 19726219
J Psychiatr Res. 2009 Jan;43(4):484-9
pubmed: 18674783
Psychiatry Investig. 2011 Jun;8(2):89-94
pubmed: 21852983
Soc Personal Psychol Compass. 2014 Feb 1;8(2):58-72
pubmed: 24839458
Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256 Suppl 1:i26-31
pubmed: 16977548
Neurotherapeutics. 2012 Jul;9(3):518-30
pubmed: 22678458
Am J Occup Ther. 2009 Jul-Aug;63(4):433-40
pubmed: 19708472
Brain Res Brain Res Rev. 2003 Jan;41(1):88-123
pubmed: 12505650
Psychiatry Res. 2015 Dec 15;230(2):357-63
pubmed: 26416589
Biol Psychiatry. 2000 Jun 1;47(11):969-77
pubmed: 10838065
Am J Occup Ther. 2007 Mar-Apr;61(2):247-53
pubmed: 17436847
J Autism Dev Disord. 2016 Jun;46(6):1962-1973
pubmed: 26864157
PLoS One. 2014 Jul 30;9(7):e103038
pubmed: 25075609
J Child Psychol Psychiatry. 2012 Jan;53(1):64-72
pubmed: 21797864
Int J Psychophysiol. 2009 May;72(2):187-97
pubmed: 19146890
Neuroimage. 2017 Jan 15;145(Pt A):58-73
pubmed: 27664824
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Front Integr Neurosci. 2019 Jul 17;13:29
pubmed: 31379528
Brain. 1998 Jan;121 ( Pt 1):47-57
pubmed: 9549487
Am J Occup Ther. 2010 May-Jun;64(3):430-42
pubmed: 20608274
Physiol Behav. 2007 Mar 16;90(4):553-8
pubmed: 17198716

Auteurs

Noor Adra (N)

Wellesley College, Wellesley, MA, USA.
Department of Psychiatry, Massachusetts General Hospital, Charlestown, MA, USA.
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

Aihua Cao (A)

Department of Psychiatry, Massachusetts General Hospital, Charlestown, MA, USA.
Department of Pediatrics, Qilu hospital of Shandong University, Jinan, 250012, Shandong, China.
Brain Science Research Institute, Shandong University, Jinan, China.

Nikos Makris (N)

Department of Psychiatry, Massachusetts General Hospital, Charlestown, MA, USA.
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

Eve M Valera (EM)

Department of Psychiatry, Massachusetts General Hospital, Charlestown, MA, USA. eve_valera@hms.harvard.edu.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA. eve_valera@hms.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH